my.chemeurope.com
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
11-02-2006: Barr Pharmaceuticals, Inc. and its newly acquired subsidiary PLIVA d.d. announced changes to the Management and Supervisory Boards of PLIVA d.d. The changes resulted from the meeting of PLIVA's Supervisory Board that was held on October 30, 2006 in Zagreb, Croatia.
Following the successful closing of Barr's acquisition of PLIVA, Barr and PLIVA announced a new combined PLIVA management team with the appointment of three new members to PLIVA's Management Board. PLIVA's Management Board will continue to be led by Zeljko ovi as President and Chief Operating Officer and Ivan Mijatovi will remain as Member and Chief Financial Officer. Joining the Management Board will be Paul M. Bisaro, President and Chief Operating Officer of Barr Pharmaceuticals, Inc., Tim Sawyer, Vice President, Sales for Generic Products in Barr Laboratories, Inc., and Zdravka Knezevi, Executive Director of Global Research and Development in PLIVA, with a mandate through to June 30, 2010.
As a result of the combination and change in structure, Mike Urwin has elected to leave the Board but has agreed to stay on for an interim period to help ensure a smooth transition during the integration of both companies.
Watchlist
This is where you can add this news to your personal favourites
Right first time: Pioneering new methods of drug manufacture
Engineers at the University of Leeds have developed a simple technology which can be used in existing chemical reactors to ensure "right first time" drug crystal formation. Ensuring drug crystals are formed correctly is crucial to their efficacy and the efficiency of pharmaceutical manufact ... more
PLIVA to File Lawsuit Against HANFA
PLIVA d.d. announced that it plans to file a lawsuit against the Croatian Financial Services Supervisory Agency (HANFA) with the Administrative Court of the Republic of Croatia, following the notification received on 22 January 2007 of HANFA's Ruling that PLIVA withheld price-sensitive info ... more
PLIVA Announces Changes in Management and Supervisory Boards
Barr Pharmaceuticals, Inc. and its newly acquired subsidiary PLIVA d.d. announced changes to the Management and Supervisory Boards of PLIVA d.d. The changes resulted from the meeting of PLIVA's Supervisory Board that was held on October 30, 2006 in Zagreb, Croatia. Following the successful ... more
PLIVA Announces Changes in Management and Supervisory Boards
Barr Pharmaceuticals, Inc. and its newly acquired subsidiary PLIVA d.d. announced changes to the Management and Supervisory Boards of PLIVA d.d. The changes resulted from the meeting of PLIVA's Supervisory Board that was held on October 30, 2006 in Zagreb, Croatia. Following the successful ... more
Actavis divests its stake in PLIVA
Actavis Group announced that a total of 20.8% of PLIVA's share capital that Actavis controls through a combination of share ownership and options to acquire shares has been tendered into Barr's offer to acquire all outstanding shares in PLIVA at HRK820 per share. The shareholding was a str ... more
Barr Acquires PLIVA d.d. Following Official Closing of Tender Offer Process
Barr Pharmaceuticals, Inc. and PLIVA d.d. announced that the Central Depository Agency ("CDA") has issued the final results of the tender process and that 17,056,977 shares, representing 92% of PLIVA's share capital, have been tendered to Barr's European subsidiary. Under the terms of Barr ... more
About CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2011 CHEMIE.DE Information Service GmbH, All rights reserved
